Masahiko Tameda

Masahiko Tameda

Auto-generated profile, based on publicly available information

Masahiko Tameda

Department of Molecular and Laboratory Medicine, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2015 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
CKChika Kasai
Chika Kasai
KSKazushi Sugimoto
Kazushi Sugimoto
IMIsao Moritani
Isao Moritani
JTJunichiro Tanaka
Junichiro Tanaka
YOYumi Oya
Yumi Oya
KTKojiro Takase
Kojiro Takase
Obesity has become one of the most serious social problems in developed countries, including Japan. The relationship between the gut microbiota and obesity has recently attracted the attention of many researchers. Although the gut microbiota was long thought to contribute to obesity, the exact association remains largely unknown. We examined the human gut microbiota composition in a Japanese population in order to determine its relationship to obesity. Stool samples from 23 non-obese subjects (body mass index [BMI] <20 kg/m2) and 33 obese subjects (BMI ≥25 kg/m2) were collected and DNA was extracted prior to colonoscopy. After terminal restriction fragment length polymorphism (T-RFLP) analysis, samples from 10 subjects (4 non-obese and 6 obese) were selected and subjected to next-generation sequencing for species-level analysis. T-RFLP analysis showed significantly reduced numbers of Bacteroidetes and a higher Firmicutes to Bacteroidetes ratio in obese subjects compared with non-obese subjects. Bacterial diversity was significantly greater in obese subjects compared with non-obese subjects. Next-generation sequencing revealed that obese and non-obese subjects had different gut microbiota compositions and that certain bacterial species were significantly associated with each group (obese: Blautia hydrogenotorophica, Coprococcus catus, Eubacterium ventriosum, Ruminococcus bromii, Ruminococcus obeum; non-obese: Bacteroides faecichinchillae, Bacteroides thetaiotaomicron, Blautia wexlerae, Clostridium bolteae, Flavonifractor plautii). Gut microbial properties differ between obese and non-obese subjects in Japan, suggesting that gut microbiota composition is related to obesity.

1 September 2010 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
SHShiraki
Shiraki
JTJunichiro Tanaka
Junichiro Tanaka
KSKazushi Sugimoto
Kazushi Sugimoto
KSKatsuya Shiraki
Katsuya Shiraki
MTMasahiko Tameda
Masahiko Tameda
YTYoshiyuki Takei
Yoshiyuki Takei
Toll-like receptor 9 (TLR9) is a pattern-recognition receptor that is involved in immune signaling and plays a crucial role in cell survival through recognition of various bacterial and viral components including unmethylated CpG-DNA. TLR9 expression and function in cancer cells are not well understood. We investigated the expression of TLR9, and the function of TLR9 signaling, in hepatocellular carcinoma (HCC) cells following stimulation with CpG-oligodeoxynucleotides (ODNs). Positive immunohistochemical staining for TLR9 was observed in 85.7% of HCC tissues. Western blot analysis revealed that TLR9 was expressed both on the cell membrane and in the cytoplasm of HCC cell lines. Full-length TLR9 was predominantly expressed on the membrane rather than in the cytoplasm, whereas multiple cleaved forms of TLR9 were predominantly expressed in the cytoplasm rather than on the membrane. Cell surface stimulation of TLR9 promoted cell proliferation, and, furthermore, the TLR9 agonists, CpG-ODNs, reduced the cytotoxicity of the anti-cancer drug adriamycin (ADM) via up-regulation of apoptosis inhibitors such as survivin, Bcl-xL, XIAP and cFLIP, in HCC cell lines. Although cell surface stimulation of TLR9 did not activate either the NF-κB signaling pathway or the type-I IFN secretion pathway, gene chip microarray analysis indicated that TLR9 agonists closely regulated multiple oncology-related genes and transcription factors involved in tumorigenesis and cancer progression. In conclusion, our results indicate that functional cell surface expression of TLR9 in human HCC may play an important role in tumorigenesis and cancer progression.

4 October 2016 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
CKChika Kasai
Chika Kasai
KSKazushi Sugimoto
Kazushi Sugimoto
IMIsao Moritani
Isao Moritani
JTJunichiro Tanaka
Junichiro Tanaka
YOYumi Oya
Yumi Oya
KTKojiro Takase
Kojiro Takase
Helicobacter pylori (H. pylori) infection and eradication therapy have been known to influence gastric ghrelin and leptin secretion, which may lead to weight gain. However, the exact relationship between plasma ghrelin/leptin levels and H. pylori infection has remained controversial. The aim of this study was to investigate plasma ghrelin and leptin levels in H. pylori-positive and -negative patients, to compare the two levels of the hormones before and after H. pylori eradication, and to examine the correlation between body mass index (BMI) and active ghrelin or leptin levels, as well as that between atrophic pattern and active ghrelin or leptin levels. Seventy-two H. pylori-positive patients who underwent upper gastrointestinal endoscopy, 46 diagnosed as having peptic ulcer and 26 as atrophic gastritis, were enrolled. Control samples were obtained from 15 healthy H. pylori-negative volunteers. The extent of atrophic change of the gastric mucosa was assessed endoscopically. Body weight was measured and blood was collected before and 12 weeks after H. pylori eradication therapy. Blood samples were taken between 8 and 10 AM after an overnight fast. Plasma ghrelin levels were significantly lower in H. pylori-positive patients than in H. pylori-negative patients. In particular, plasma active ghrelin levels were significantly lower in patients with gastritis compared with patients with peptic ulcer. Plasma ghrelin levels decreased after H. pylori eradication in both peptic ulcer and gastritis patients, while plasma leptin levels increased only in peptic ulcer patients. Plasma leptin levels and BMI were positively correlated, and active ghrelin levels and atrophic pattern were weakly negatively correlated in peptic ulcer patients. H. pylori infection and eradication therapy may affect circulating ghrelin/leptin levels. This finding suggests a relationship between gastric mucosal injury induced by H. pylori infection and changes in plasma ghrelin and leptin levels.

1 December 2013 in Endoscopy
Verified
Journal Article
Closed access
HIHiroyuki Inoue
Hiroyuki Inoue
MTMasahiko Tameda
Masahiko Tameda
RYReiko Yamada
Reiko Yamada
STShunske Tano
Shunske Tano
MKMasaki Kasturahara
Masaki Kasturahara
YTYoshiyuki Takei
Yoshiyuki Takei
A 65-year-old man was referred to our hospital with obstructive jaundice. Laboratory tests showed elevated levels of alkaline phosphatase (1932 U/L; normal range 35 – 104 U/L), γ-glutamyltransferase (1030 U/L; normal value < 39 U/L), and bilirubin (3.6 mg/dL; normal value < 1.2 mg/dL). The tumor antigen CA 19-9 was also elevated (226.4 U/L; normal value < 37 U/L). Abdominal computed tomography showed a well-demarcated mass in the head of the pancreas ([Fig. 1]). This was 4 cm in diameter with a heterogeneous enhancing pattern. Endoscopic retrograde cholangiopancreatography showed a smooth stricture of the distal common bile duct ([Fig. 2]), and a plastic biliary stent (8.5 Fr, 7 cm) was inserted into the bile duct. Although endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was carried out ([Fig. 3]), definitive diagnoses could not be made because the samples from EUS-FNA contained only normal-looking pancreatic tissue. Pancreaticoduodenectomy was performed. Microscopically, the specimen showed a well-demarcated solid mass ([Fig. 4]), and the tumor was composed of non-neoplastic acinar and ductal cells embedded in a hypocellular fibrous stroma ([Fig. 5]). Immunohistochemically, the spindle-shaped stromal cells were positive for CD34 and negative for c-kit. The ductal components were positive for S-100. The histological diagnosis was pancreatic hamartoma. There was no evidence of recurrence up to 3 years after surgery. Pancreatic hamartoma is a non-neoplastic, mass-forming lesion of the pancreas and is extremely rare. The pathogenesis of these tumors remains unknown. The major histopathological features of pancreatic hamartoma are mature acini and small to medium-sized ducts showing a distorted architecture with various amounts of fibrous stroma. Immunohistochemically, the ductal components are positive for S-100 and the spindle-shaped stromal cells express CD34 and/or c-kit [1] [2]. Weight loss and abdominal pain are the most common symptoms characterizing pancreatic hamartoma. To the best of our knowledge, our report describes the first case of pancreatic hamartoma manifesting initially as obstructive jaundice. Endoscopy_UCTN_Code_CCL_1AF_2AZ_3AB

1 December 2010
Verified
Journal Article
Closed access
MSMasahiro Suzuki
Masahiro Suzuki
KSKazushi Sugimoto
Kazushi Sugimoto
JTJunichiro Tanaka
Junichiro Tanaka
MTMasahiko Tameda
Masahiko Tameda
YIYuji Inagaki
Yuji Inagaki
KSKatsuya Shiraki
Katsuya Shiraki

21 July 2010 in International Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
SHShiraki
Shiraki
TBTetsuya Beppu
Tetsuya Beppu
KSKazushi Sugimoto
Kazushi Sugimoto
KSKatsuya Shiraki
Katsuya Shiraki
MTMasahiko Tameda
Masahiko Tameda
KTKan Takeda
Kan Takeda
The aim of this study was to elucidate the importance of three tumor markers, α-fetoprotein (AFP), Lens culinaris agglutinin A-reactive fraction of AFP (AFP-L3), and des-γ-carboxy prothrombin (DCP), for detecting and predicting the recurrence of hepatocellular carcinomas (HCCs). A total of 108 patients with initial non-advanced HCC who underwent curative radiofrequency ablation (RFA) in our hospital were enrolled in this study. The effectiveness of the three tumor markers for detecting recurrence and recurrence-free survival was analyzed. Positivity of these three makers was not markedly increased at the first or second recurrence. In addition, there was no significant correlation between the initial and recurrent levels of each tumor marker. The tumor marker that was positive at the time of initial HCC was not necessarily positive at recurrence. The tumor marker levels at recurrence were not correlated with pre-ablation levels. No significant correlation was found in the tumor marker values between pre-ablation and the time of recurrence. On multivariate analysis, high AFP-L3 levels (≥10%) were significantly predictive of recurrence-free survival. All three tumor markers should be routinely measured to detect recurrence during follow-up after RFA. Especially high AFP-L3 levels should be followed closely.